Paraneoplastic Pemphigus Revealed by Anti-programmed Death-1 Pembrolizumab Therapy for Cutaneous Squamous Cell Carcinoma Complicating Hidradenitis Suppurativa

Paraneoplastic Pemphigus Revealed by Anti-programmed Death-1 Pembrolizumab Therapy for Cutaneous Squamous Cell Carcinoma Complicating Hidradenitis Suppurativa

A 64-year-old patient developed a widespread autoimmune mucocutaneous blistering disease 3 weeks after the initiation of the anti-programmed death-1 (anti-PD-1) pembrolizumab therapy administered for a locally advanced cutaneous squamous cell carcinoma (SCC) of the buttocks arising from hidradenitis...

Full description

Bibliographic Details
Main Authors: Ahmad Yatim, Gérôme Bohelay, Sabine Grootenboer-Mignot, Catherine Prost-Squarcioni, Marina Alexandre, Christelle Le Roux-Villet, Antoine Martin, Eve Maubec, Frédéric Caux
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-11-01
Series:Frontiers in Medicine
Subjects:
paraneoplastic pemphigus
immune checkpoints inhibitors
anti-programmed-death-1
pembrolizumab
cutaneous squamous cell carcinoma
hidradenitis suppurativa
Online Access:https://www.frontiersin.org/article/10.3389/fmed.2019.00249/full

Internet

https://www.frontiersin.org/article/10.3389/fmed.2019.00249/full

Similar Items